» Articles » PMID: 28027286

Relationship of the Middle Ear Effusion Microbiome to Secretory Mucin Production in Pediatric Patients With Chronic Otitis Media

Overview
Specialty Pediatrics
Date 2016 Dec 28
PMID 28027286
Citations 23
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Acute otitis media, an infection of the middle ear, can become chronic after multiple episodes. Microbial influence on chronic otitis media remains unclear. It has been reported that mucin glycoproteins are required for middle ear immune defense against pathogens. We aim to characterize the middle ear effusion (MEE) microbiome using high-throughput sequencing and assess potential associations in microbiome diversity with the presence of the secretory mucins MUC5B and MUC5AC. We hypothesize that MEEs containing MUC5B will exhibit a microbiome largely devoid of typical acute otitis media bacteria.

Methods: Fifty-five MEEs from children undergoing myringotomy at Children's National Health System were recovered. Mucin was semiquantitatively determined through Western blot analysis. DNA was subjected to 16S rRNA amplicon sequencing using the Illumina MiSeq platform. Raw data were processed in mothur (SILVA reference database). Alpha- and beta-diversity metrics were determined. Abundance differences between sample groups were estimated.

Results: MUC5B was present in 94.5% and MUC5AC in 65.5% of MEEs. Sequencing revealed 39 genera with a relative abundance ≥0.1%. Haemophilus (22.54%), Moraxella (11.11%) and Turicella (7.84%) were the most abundant. Turicella and Pseudomonas proportions were greater in patients older than 24 months of age. In patients with hearing loss, Haemophilus was more abundant, while Turicella and Actinobacteria were less abundant. Haemophilus was also more abundant in samples containing both secretory mucins.

Conclusions: The microbiome of MEEs from children with chronic otitis media differs according to specific clinical features, such as mucin content, age and presence of hearing loss. These associations provide novel pathophysiologic insights across the spectrum of otitis media progression.

Citing Articles

Clinical study of the effect of mometasone furoate nasal spray treatment on hearing and in secretory otitis media in children.

Yu X, Xu L, Xie Y, Huang M Clinics (Sao Paulo). 2024; 80:100551.

PMID: 39671881 PMC: 11699745. DOI: 10.1016/j.clinsp.2024.100551.


Characterization of middle ear microbiome in otitis media with effusion in Hungarian children: may potentially hamper the microbial diversity.

Fekete S, Juhasz J, Makra N, Dunai Z, Kristof K, Ostorhazi E Heliyon. 2024; 10(21):e39380.

PMID: 39524746 PMC: 11547888. DOI: 10.1016/j.heliyon.2024.e39380.


Metabolism and gene sequence variation in Turicella otitidis implies its adaptability and pathogenicity in extra-otic infection: a systematic review.

Ahamad A, Yuan C, Chung C, Blair B, Tran A, Tehreem B BMC Infect Dis. 2023; 23(1):735.

PMID: 37891485 PMC: 10612267. DOI: 10.1186/s12879-023-08721-y.


Ensuring the future of otitis media research: Interest in and feasibility of a mentoring network program within the otitis media research community.

Ziniel S, Preciado D, Lee R, Kerschner J, Ryan A, Santos-Cortez R Int J Pediatr Otorhinolaryngol. 2023; 172:111693.

PMID: 37579520 PMC: 10523683. DOI: 10.1016/j.ijporl.2023.111693.


IL-17 is a Potential Therapeutic Target in a Rodent Model of Otitis Media with Effusion.

Zhang N, Qian T, Sun S, Cao W, Wang Z, Liu D J Inflamm Res. 2022; 15:635-648.

PMID: 35140496 PMC: 8818970. DOI: 10.2147/JIR.S338598.